Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
Ixekizumab With or Without Tirzepatide in Adults With Psoriasis and Overweight or Obesity: A Phase 3b Randomized Clinical Trial.
Journal: JAMA dermatology
Published: May 15, 2026
Ixekizumab in children with active psoriatic and enthesitis-related juvenile idiopathic arthritis (COSPIRIT-JIA): a multicentre, open-label, 16-week, Bayesian trial including a randomised reference group to adalimumab.
Journal: The Lancet. Rheumatology
Published: March 14, 2025
Serum biomarkers associated with baricitinib response in patients with juvenile idiopathic arthritis: a post-hoc analysis of the phase 3 JUVE-BASIS trial.
Journal: The Lancet. Rheumatology
Published: December 09, 2024
A population pharmacokinetic model using allometric scaling for baricitinib in patients with juvenile idiopathic arthritis.
Journal: CPT: pharmacometrics & systems pharmacology
Published: January 18, 2023
Time Motion Analysis: Impact of Scribes on Provider Time Management.
Journal: The Journal of emergency medicine
Published: January 06, 2018
Showing 1-5 of 5
Last Updated: 09/26/2026